Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Kuusela

Showing results (31-40 of 96) with videos related to

Pageof 10
Sort By:
FEMS Microbiology Letters|February 1, 1993
Immobilization of plasminogen on Escherichia coli flagellaK Lähteenmäki, B Westerlund, P Kuusela, et al.
Anticancer Research|September 1, 1995
Prognostic significance of serum CA 242 in pancreatic cancer. A comparison with CA 19-9J Lundin, P J Roberts, P Kuusela, et al.
The Journal of Infectious Diseases|December 1, 1992
Binding of plasminogen to Neisseria meningitidis and Neisseria gonorrhoeae and formation of surface-associated plasminM Ullberg, P Kuusela, B E Kristiansen, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|December 1, 1983
Reactivity of amniotic fluid alpha-fetoprotein with concanavalin A-sepharose in pre-natal diagnosis of fetal malformationsK L Kolho, P Kuusela, M Heikinheimo, et al.
International Journal of Cancer|April 15, 1987
Serum CA 50 as a tumor marker in pancreatic cancer: a comparison with CA 19-9C Haglund, P Kuusela, H Jalanko, et al.
Infection and Immunity|August 1, 1984
Binding sites for streptococci and staphylococci in fibronectinP Kuusela, T Vartio, M Vuento, et al.
Infection and Immunity|October 1, 1985
Attachment of staphylococci and streptococci on fibronectin, fibronectin fragments, and fibrinogen bound to a solid phaseP Kuusela, T Vartio, M Vuento, et al.
British Journal of Cancer|June 1, 1987
Comparison of CA-50, a new tumour marker, with carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in patients with gastrointestinal diseasesP Kuusela, C Haglund, P J Roberts, et al.
British Journal of Cancer|March 1, 1994
The prognostic value of preoperative serum levels of CA 19-9 and CEA in patients with pancreatic cancerJ Lundin, P J Roberts, P Kuusela, et al.
British Journal of Cancer|September 1, 1994
CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEAC Haglund, J Lundin, P Kuusela, et al.
Pageof 10

Showing results (31-40 of 96) with videos related to

Sort By:
Pageof 10
FEMS Microbiology Letters|February 1, 1993
Immobilization of plasminogen on Escherichia coli flagellaK Lähteenmäki, B Westerlund, P Kuusela, et al.
Anticancer Research|September 1, 1995
Prognostic significance of serum CA 242 in pancreatic cancer. A comparison with CA 19-9J Lundin, P J Roberts, P Kuusela, et al.
The Journal of Infectious Diseases|December 1, 1992
Binding of plasminogen to Neisseria meningitidis and Neisseria gonorrhoeae and formation of surface-associated plasminM Ullberg, P Kuusela, B E Kristiansen, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|December 1, 1983
Reactivity of amniotic fluid alpha-fetoprotein with concanavalin A-sepharose in pre-natal diagnosis of fetal malformationsK L Kolho, P Kuusela, M Heikinheimo, et al.
International Journal of Cancer|April 15, 1987
Serum CA 50 as a tumor marker in pancreatic cancer: a comparison with CA 19-9C Haglund, P Kuusela, H Jalanko, et al.
Infection and Immunity|August 1, 1984
Binding sites for streptococci and staphylococci in fibronectinP Kuusela, T Vartio, M Vuento, et al.
Infection and Immunity|October 1, 1985
Attachment of staphylococci and streptococci on fibronectin, fibronectin fragments, and fibrinogen bound to a solid phaseP Kuusela, T Vartio, M Vuento, et al.
British Journal of Cancer|June 1, 1987
Comparison of CA-50, a new tumour marker, with carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in patients with gastrointestinal diseasesP Kuusela, C Haglund, P J Roberts, et al.
British Journal of Cancer|March 1, 1994
The prognostic value of preoperative serum levels of CA 19-9 and CEA in patients with pancreatic cancerJ Lundin, P J Roberts, P Kuusela, et al.
British Journal of Cancer|September 1, 1994
CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEAC Haglund, J Lundin, P Kuusela, et al.
Pageof 10